Evidence map›Paper›PMID 11429693›Full record

ArticleOncogene2001

The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway.

K Abe, M Hirai, K Mizuno, N Higashi, T Sekimoto, T Miki, T Hirano, K Nakajima

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2012
    Article
  14. Article
  15. Article
  16. STAT3 and cardiac remodeling.Heart failure reviews · 2011
    Review
  17. Article
  18. Article
  19. LIGHT, a member of the TNF superfamily, activates Stat3 mediated by NIK pathway.Biochemical and biophysical research communications · 2007
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

K AbeDepartment of Immunology, Osaka City University Graduate School of Medicine, Osaka, 545-8585 Japan.
M Hirai
K Mizuno
N Higashi
T Sekimoto
T Miki
T Hirano
K Nakajima
Osaka City University · JPOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The signal transducer and activator of transcription (STAT) 3 is essential for mediating signals from the receptors for a variety of cytokines and growth factors, including IL-6 and EGF, and from cytoplasmic tyrosine kinases. Upon stimulation, STAT3 is phosphorylated at Ser727 and Tyr705. However, the role of phosphorylation at Ser727, and the kinase pathways responsible for this phosphorylation in IL-6 signaling remain obscure. Here we show that IL-6 activates at least two distinct STAT3 serine kinase pathways and that an H7-sensitive pathway is dominant over a PD98059-sensitive one in HepG2 cells stimulated with a low concentration of IL-6. The analysis, using a series of chimeric receptors containing the extracellular domain of the G-CSF receptor, the truncated form of gp 130, and additional short peptides at the gp 130 carboxy-terminus, showed that the YXXQ motif of gp 130 was sufficient for the H7-sensitive STAT3 Ser727 phosphorylation. This YXXQ-mediated pathway does not involve Erk, p38, JNK, or PKCdelta, and requires a site in the region from 533 to 711 of STAT3 for phosphorylation in vivo. Moreover, we show that Ser727 is required for full transcriptional activity of STAT3 for two different response elements. Thus, the YXXQ motif regulates STAT3 activities in two ways in response to even a low concentration of IL-6: it recruits STAT3 to the receptor for tyrosine phosphorylation, and activates an unidentified H7-sensitive pathway leading to the serine phosphorylation of STAT3.

Indexed as

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine3T3 CellsAlanineAmino Acid SequenceAmino Acid SubstitutionAnimalsAntigens, CDBinding SitesCarcinoma, HepatocellularCell LineCytokine Receptor gp130DNA-Binding ProteinsDNA PrimersEnzyme InhibitorsFlavonoidsGranulocyte Colony-Stimulating Factor1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneAlanineAntigens, CDCytokine Receptor gp130DNA-Binding ProteinsDNA PrimersEnzyme InhibitorsFlavonoidsGranulocyte Colony-Stimulating FactorIL6ST protein, humanIl6st protein, mouseInterferon-gammaInterleukin-6Membrane GlycoproteinsMitogen-Activated Protein KinasesProtein KinasesRecombinant Fusion ProteinsRecombinant ProteinsSerineSTAT3 protein, humanStat3 protein, mouseSTAT3 Transcription FactorTetradecanoylphorbol AcetateTrans-ActivatorsTumor Necrosis Factor-alpha

Identifiers

PMID11429693
OpenAlexW2070104907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.